---
title: "Understanding the Market | JACOBIO-B rose over 7% during the session as the company divests non-core projects to focus on its core pipeline of innovative oncology drugs"
description: "JACOBIO-B rose over 7% during the trading session, and as of the time of writing, it is up 6.12%, priced at HKD 7.8, with a transaction volume of HKD 23.9374 million. In terms of news, JACOBIO previou"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261807161.md"
published_at: "2025-10-20T03:54:05.000Z"
---

# Understanding the Market | JACOBIO-B rose over 7% during the session as the company divests non-core projects to focus on its core pipeline of innovative oncology drugs

> JACOBIO-B rose over 7% during the trading session, and as of the time of writing, it is up 6.12%, priced at HKD 7.8, with a transaction volume of HKD 23.9374 million. In terms of news, JACOBIO previously announced that it has signed a capital increase and equity transfer agreement with Haisong Capital and an industrial partner. According to this agreement, Haisong Capital will acquire 80% of the equity of JACOBIO's subsidiary, JACOREKANG, with an initial payment of RMB 125 million and a milestone payment of RMB 75 million. After completion, JACOBIO's stake in JACOREKANG will be reduced to 10%. The announcement stated that this transaction aligns with the group's strategic development focused on key pipeline products in oncology targeting different critical cellular pathways (including KRAS, MYC, P53, and tumor immunity), optimizing capital allocation, fully ensuring the development of core oncology pipeline projects, achieving strategic focus, enhancing organizational efficiency, while retaining future project value through a risk-sharing model. The consideration for the equity transfer (after deducting various taxes and fees) is intended to be used for the research and development, production, and commercialization of the company's Pan-KRAS inhibitors and other innovative oncology projects

According to Zhitong Finance APP, JACOBIO-B (01167) rose over 7% during the trading session, and as of the time of writing, it was up 6.12%, priced at HKD 7.8, with a transaction volume of HKD 23.9374 million.

In terms of news, JACOBIO previously announced that it had signed a capital increase and equity transfer agreement with Haisong Capital and an industrial partner. According to this agreement, Haisong Capital will acquire 80% of the equity of JACOBIO's subsidiary, JACOREKANG, with an initial payment of RMB 125 million and a milestone payment of RMB 75 million. After completion, JACOBIO's shareholding in JACOREKANG will be reduced to 10%.

The announcement stated that the transaction aligns with the group's strategic development focused on key pipeline products in oncology targeting different critical cell pathways (including KRAS, MYC, P53, and tumor immunity), optimizing capital allocation, fully ensuring the development of core oncology pipeline, achieving strategic focus, enhancing organizational efficiency, while retaining future project value through a risk-sharing model. The consideration for the equity transfer (after deducting various taxes and fees) is intended for the research and development, production, and commercialization of the company's Pan-KRAS inhibitors and other innovative oncology projects

### Related Stocks

- [01167.HK - JACOBIO-B](https://longbridge.com/en/quote/01167.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 緬因州疾病控制與預防中心報告稱，緬因州已確認新增 4 例麻疹病例 | 緬因州疾病控制中心報告緬因州新增 4 例麻疹確診病例 | [Link](https://longbridge.com/en/news/276164223.md) |
| Verana Health 推出業內首個完整的泌尿腫瘤數據集，以支持相關研究 | Verana Health 推出了新的泌尿腫瘤數據集，旨在增強膀胱癌和前列腺癌治療的研究。這些數據集提供了對患者經歷的全面縱向洞察，解決了治療可見性和決策過程中的空白。該公告恰逢 ASCO 泌尿系統癌症研討會，研究人員可以瞭解更多關於這些數 | [Link](https://longbridge.com/en/news/276359690.md) |
| 08:46 ET 石棉相關疾病中心（CARD）邀請社區成員參加開放日和剪彩儀式 | 石棉相關疾病中心（CARD）將於 2025 年 2 月 24 日下午 3:00 至 5:00 在其位於利比的新址舉辦開放日和剪綵慶祝活動。此次活動旨在與社區重新建立聯繫，展示新設施，並向與會者介紹可用的服務，包括免費的石棉健康篩查和肺癌篩查 | [Link](https://longbridge.com/en/news/276235741.md) |
| 定期牙科檢查如何促進佛羅里達州維羅海灘的口腔健康 | 定期的牙科檢查對維護口腔健康和預防嚴重的醫療問題至關重要。它們通過去除牙菌斑來預防蛀牙，及早發現牙齦疾病，並監測口腔健康隨時間的變化。牙醫還可以識別其他健康問題的跡象，例如睡眠呼吸暫停或癌症。在佛羅里達州維羅海灘的常規檢查支持主動的口腔護理 | [Link](https://longbridge.com/en/news/276145403.md) |
| 稀有疾病每生命基金會在國會山舉辦第 15 屆年度稀有疾病周活動 | 每生命基金會將於 2026 年 2 月 24 日至 26 日在華盛頓特區的國會山舉辦第 15 屆年度罕見疾病周。此次免費活動旨在提升罕見疾病患者的聲音並推動相關政策。2026 年的新亮點包括增加半天的故事講述和倡導活動、更新的立法會議以及參 | [Link](https://longbridge.com/en/news/276247135.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
